Depreciation of VYNE Therapeutics Inc. from 31 Dec 2022 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
VYNE Therapeutics Inc. annual and quarterly Depreciation in USD history and change rate from 31 Dec 2022 to 31 Dec 2025.
  • VYNE Therapeutics Inc. Depreciation for the quarter ending 30 Jun 2025 was $6,000.
  • VYNE Therapeutics Inc. annual Depreciation for 2025 was $23,000, a 475% increase from 2024.
  • VYNE Therapeutics Inc. annual Depreciation for 2024 was $4,000.
  • VYNE Therapeutics Inc. annual Depreciation for 2023 was $0, a 100% decline from 2022.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Quarterly (USD)

VYNE Therapeutics Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $23,000 +$19,000 +475% 01 Jan 2025 31 Dec 2025 10-K 27 Feb 2026 2025 FY
2024 $4,000 +$4,000 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2026 2025 FY
2023 $0 -$100,000 -100% 01 Jan 2023 31 Dec 2023 10-K 06 Mar 2025 2024 FY
2022 $100,000 01 Jan 2022 31 Dec 2022 10-K 01 Mar 2024 2023 FY

VYNE Therapeutics Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $6,000 +$6,000 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $6,000 +$6,000 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q2 2024 $0 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 $0 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.